SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?


To: Mike Lee who wrote (99807)4/24/2000 11:29:00 AM
From: vagabond  Respond to of 108040
 
Mike: I could certainly be wrong, but the AVE drug does sound pretty good to me as a valuable alternative treatment for diabetes patients -- and the PR does say it's the FIRST drug of its kind (first approved "biosynthetic" insulin that only requires a once-a-day shot). Anyway, curious to see if/how the stock reacts. Of course, the fact that it's on the NYSE rather than the NAZ is a negative...

Vagabond